pyruvaldehyde has been researched along with Acquired Metabolic Diseases, Brain in 1 studies
Pyruvaldehyde: An organic compound used often as a reagent in organic synthesis, as a flavoring agent, and in tanning. It has been demonstrated as an intermediate in the metabolism of acetone and its derivatives in isolated cell preparations, in various culture media, and in vivo in certain animals.
methylglyoxal : A 2-oxo aldehyde derived from propanal.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, R | 1 |
| Okouchi, M | 1 |
| Kato, T | 1 |
| Imaeda, K | 1 |
| Okayama, N | 1 |
| Asai, K | 1 |
| Joh, T | 1 |
1 other study available for pyruvaldehyde and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis.
Topics: Animals; Apoptosis; Brain Diseases, Metabolic; Cytoprotection; Diabetes Complications; ErbB Receptor | 2013 |